What is HeartSciences Inc. (HSCSW)?

HeartSciences Inc. (HSCSW) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of HSCSW?

The current price of HSCSW is $0.09. Prices are updated in real time on Stocks360.

What is HSCSW's price-to-earnings (PE) ratio?

HSCSW's trailing twelve-month PE ratio is -1.02, based on current price and earnings per share data available on Stocks360.

What is HSCSW's market capitalization?

HSCSW's market capitalization is $227,703.00, placing it in the small-cap tier.

HeartSciences Inc. (HSCSW)

Stock analysis · NASDAQ · Healthcare · Medical - Devices

$0.09

Market Cap

$227.70K

PE (TTM)

-1.02

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.86

Day Range

$0.07 – $0.09

52-wk Range

$0.03 – $0.18

Avg Volume

N/A

Volume

9.70K

HeartSciences Inc. (HSCSW) is a publicly traded company in the Healthcare sector. Latest price: $0.09. Market cap $227.70K. Trailing PE -1.02. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 17 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-28 · $0.07 2026-10-27 · $0.09 (+19.78%)

Earnings

Most Recent

Sep 16, 2026

EPS $-0.86 vs est. $-0.72

Missed by $0.14

Next Earnings

Dec 10, 2026

EPS estimate $-0.62

Proprietary Signals

Signal snapshot temporarily unavailable.

About HeartSciences Inc.

Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph. This device provides essential diagnostic insights into cardiac dysfunction, in addition to supplying standard 12-lead resting ECG information. Serving a diverse range of medical environments, its products are adopted by clinics, physicians' offices, urgent care centers, and hospitals. Founded in 2007, the firm's operations are headquartered in Southlake, Texas.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-1.02×
P/S (TTM)	3515.83×
P/B	-5.92×
P/FCF (TTM)	-0.01×
EV / EBITDA	1.07×
EV / Sales	-2215.86×
Earnings Yield	-85.25%
Free Cash Flow Yield	-8335.69%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$10.01M
Net Income (TTM)	-$13.54M
Free Cash Flow (TTM)	-$1.32B
Net Debt	-$25.90M
Working Capital	-$4.95M
Gross Margin	-2908.83%
Operating Margin	-209733.08%
Net Margin	-227024.23%
Return on Equity	-816.25%
Return on Invested Capital	-480.77%